Da‐Qiang Li
Impact in
- Cancer Research top 1%
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
- Molecular Biology top 2%
- RNA modifications and cancer
- Epigenetics and DNA Methylation
- Histone Deacetylase Inhibitors Research
- Ubiquitin and proteasome pathways
Papers in
-
- Ubiquitin and proteasome pathways 19
- Histone Deacetylase Inhibitors Research 15
- RNA modifications and cancer 13
- Epigenetics and DNA Methylation 12
- DNA Repair Mechanisms 9
- RNA Research and Splicing 9
- Genomics and Chromatin Dynamics 9
- Oncology 24
- Peptidase Inhibition and Analysis 8
- Co-authors
- Rakesh Kumar (13 shared papers)Yi‐Zhou Jiang (10 shared papers)Xi Jin (8 shared papers)Xin Hu (10 shared papers)Sujit S. Nair (6 shared papers)Ding Ma (7 shared papers)Zhi‐Ming Shao (9 shared papers)Suresh B. Pakala (12 shared papers)
- Journals
- Cancer Research (7 papers)Journal of Biological Chemistry (7 papers)Clinical and Translational Medicine (4 papers)Cancer Letters (4 papers)Cell Metabolism (3 papers)
- Partner nations
- ChinaUnited StatesLaos
In The Last Decade
Da‐Qiang Li
101 papers receiving 5.1k citations
Da‐Qiang Li's Hit Papers
Peers
Comparison fields: 5 of 125
- Cancer Research 1.1k
- Molecular Biology 3.2k
- Oncology 1.1k
- Cell Biology 405
- Pulmonary and Respiratory Medicine 694
Countries citing papers authored by Da‐Qiang Li
This map shows the geographic impact of Da‐Qiang Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Da‐Qiang Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Da‐Qiang Li more than expected).
Fields of papers citing papers by Da‐Qiang Li
This network shows the impact of papers produced by Da‐Qiang Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Da‐Qiang Li. The network helps show where Da‐Qiang Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Da‐Qiang Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 103 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Ferroptosis heterogeneity in triple-negative breast cancer reveals an innovative immunotherapy combination strategy Hit paper breakdown → | 2022 | 437 |
| 2 | 2009 | 423 | |
| 3 | Metabolic-Pathway-Based Subtyping of Triple-Negative Breast Cancer Reveals Potential Therapeutic Targets Hit paper breakdown → | 2020 | 318 |
| 4 | The microbial metabolite trimethylamine N-oxide promotes antitumor immunity in triple-negative breast cancer Hit paper breakdown → | 2022 | 293 |
| 5 | Comprehensive metabolomics expands precision medicine for triple-negative breast cancer Hit paper breakdown → | 2022 | 221 |
| 6 | 2016 | 180 | |
| 7 | 2007 | 156 | |
| 8 | 2020 | 149 | |
| 9 | 2006 | 126 | |
| 10 | 2012 | 116 | |
| 11 | 2012 | 113 | |
| 12 | 2019 | 100 | |
| 13 | 2012 | 98 | |
| 14 | 2018 | 87 | |
| 15 | 2018 | 82 | |
| 16 | 2019 | 81 | |
| 17 | 2009 | 75 | |
| 18 | 2013 | 73 | |
| 19 | 2020 | 72 | |
| 20 | 2012 | 67 |
About Da‐Qiang Li
Da‐Qiang Li is a scholar working on Molecular Biology, Oncology, Cancer Research, Cell Biology and Pathology and Forensic Medicine, having authored 103 papers that have together received 5.2k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (19 papers), Histone Deacetylase Inhibitors Research (15 papers), RNA modifications and cancer (13 papers), Epigenetics and DNA Methylation (12 papers), DNA Repair Mechanisms (9 papers), RNA Research and Splicing (9 papers), Genomics and Chromatin Dynamics (9 papers) and Peptidase Inhibition and Analysis (8 papers). The work is most often cited by research in Cancer Research (1.1k citations), Molecular Biology (3.2k citations), Oncology (1.1k citations), Cell Biology (405 citations) and Pulmonary and Respiratory Medicine (694 citations). Da‐Qiang Li has collaborated with scholars based in China, United States and Laos. Frequent co-authors include Rakesh Kumar, Yi‐Zhou Jiang, Xi Jin, Xin Hu, Sujit S. Nair, Ding Ma, Zhi‐Ming Shao, Suresh B. Pakala, Jeyanthy Eswaran and Yi Xiao. Their work appears in journals such as Cancer Research, Journal of Biological Chemistry, Clinical and Translational Medicine, Cancer Letters and Cell Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.